Mark Bur's Colleagues at Terumo Cardiovascular
Mark Bur's Contact Details
N/A
Terumo Cardiovascular
Mark Bur's Company Details
Terumo Cardiovascular manufactures and markets medical devices for cardiac and vascular surgery with an emphasis on cardiopulmonary bypass and intra-operative monitoring. The company is headquartered in Ann Arbor, Michigan, with manufacturing operations in the U.S., Europe and Asia. It is one of several subsidiaries of Terumo Corporation of Japan that is focused exclusively on cardiovascular surgery specialties. Our parent company, Terumo Corporation, is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for nearly 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide, to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been bolstering healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large. This is the official LinkedIn account of Terumo Cardiovascular in the U.S. It is intended for medical professionals and is not a substitute for medical advice nor promotion of any medical procedure or product. Please be advised that not all of our products shown on this account are registered in, approved for sale in, or available for purchase in, all countries or regions where this account is accessible. We make no warranty as to the accuracy, up-to-datedness, utility, completeness or other qualities of the information contained herein. Reliance on any information provided herein is solely at your own risk. We are not responsible for, nor make any warranty or recommendation of, any third-party contents appearing on this account, including but not limited to, advertisement, recommendation, and comments.